Weight loss care is leading IPO-hopeful Omada Health's latest growth surge as Ozempic boom continuesOmada Health's weight loss program is driving its growth and public market ambitions, with a notable shift towards GLP-1 care.
Exclusive: Diabetes startup Omada Health has confidentially filed its S-1 to go publicOmada Health has confidentially filed for an IPO, indicating a significant step towards public markets for healthcare startups.